Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,083 total articles
Horizon Kinetics Asset Management LLC, already a roughly 10% holder of Texas Pacific Land Corp (NYSE: TPL), reported buying a single share of the company on March 31, 2026 for $470.18. The firm now directly holds 3,467,937 TPL shares. The trade comes amid a mixed quarterly report and a significant price-target increase from KeyBanc, which cited pow…
A director at Energy Vault Holdings, Inc. filed a Form 4 disclosing a $40,120 purchase of company stock on March 31, 2026. The transaction came as the share price hovered near $3.22 after a recent pullback. The company also reported fourth-quarter 2025 earnings that beat analyst expectations and announced the acquisition of a 175 MW battery energy …
Saba Capital Management, L.P., a roughly 10% holder of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), executed two sales on March 30-31, 2026, disposing of 262,345 shares of common stock for a total of $3,594,044. The trades lowered Saba’s stake to 22,022,163 shares. ECAT was trading at $13.89 at the time of reporting, close to its 52-…
Darrell E. Hollek, a director at Oil States International (NYSE: OIS), disposed of 42,511 shares on March 31, 2026, receiving about $493,552 at a weighted average price of $11.61 per share. The transaction left Hollek with 104,073 shares. The sale comes amid substantial stock appreciation over the past year and mixed fourth-quarter 2025 results for…
Harvard Bioscience Chief Financial Officer Mark T. Frost acquired 5,000 shares of the company's common stock on March 16, 2026, paying $5.00 per share for a $25,000 purchase. The transaction, disclosed in an April 1, 2026 SEC filing that accounts for a 10-for-1 reverse split on March 13, 2026, leaves Frost with 17,500 shares when including restrict…
Japan Post Holdings Co., Ltd., which holds roughly ten percent of Aflac Inc., sold 14,700 Aflac shares on March 30, 2026, for about $1.59 million. The shares were sold through an indirect trust structure; the company remains a substantial shareholder. Separately, Aflac reported fourth-quarter 2025 results that missed EPS expectations but topped rev…
Tonix Pharmaceuticals CEO Seth Lederman purchased 5,000 shares of company stock on March 31, 2026, totaling $63,099 at a weighted average price of $12.62. The acquisition coincides with recent clinical milestones for the company, including Phase 3 positive results for fibromyalgia drug TONMYA and the start of a Phase 1 study for an intranasal oxyto…
Rex American Resources Corp's finance chief sold 5,000 shares on March 31, 2026, generating $227,049 in proceeds as the stock trades close to its 52-week peak. The transaction leaves the executive with a substantial direct holding, while market metrics and recent quarterly results present a mixed picture of valuation and operational performance.
William A. Houlihan, a director at Lument Finance Trust, purchased 5,000 shares on March 27, 2026, bringing his direct holdings to 260,732 shares. The trade occurred as the stock traded near $1.26 and followed a weak fourth-quarter performance that missed consensus on both EPS and revenue. The company offers a high dividend yield and a low price-to…
Carlos Lawrence Heard, Senior Vice President and Chief Financial Officer of Saul Centers, Inc. (BFS), purchased 500 shares of the company's Series D Preferred Stock on March 30, 2026, paying $20.60 per share for a total of $10,300. The transaction raises his direct holdings of Series D preferred shares to 4,500 and follows the REIT's announcement o…
Christopher Longhito, FMR SVP & CSCO of Global Industrial Co (NYSE:GIC), reported sales of company common stock totaling $385,013 across multiple transactions between March 23 and March 27, 2026, according to a Form 4 filing. The filing also records option exercises on March 27 to acquire 4,911 shares for $131,775. The stock is trading at $31.52 an…
Curis INC director Kenneth I. Kaitin purchased 10,000 common shares on March 31, 2026, investing $5,487 at $0.5487 per share. The acquisition comes while the stock trades near its 52-week low of $0.50 and following a reported Q4 2025 net income of $19.4 million driven by a one-time gain from the sale of royalty rights. After the transaction, Kaitin…
Richard P. Hamada, a director at Keysight Technologies, sold 870 shares of company stock on March 30, 2026, in a transaction totaling $239,929. The sale, reported on a Form 4 filing with the Securities and Exchange Commission, occurred as Keysight rolled out several product and testing updates spanning cybersecurity compliance tooling, high-speed E…
US Energy Corp (USEG) Chief Executive Smith Ryan Lewis purchased 15,000 shares on March 31, 2026, for $13,050, increasing his direct holdings to 1,118,769 shares. The transaction occurs alongside the company’s planned processing facility at the Big Sky Carbon Hub in Montana and recent equity financings that include an underwritten offering and a la…
John Kent Walker, Alphabet Inc.'s President, Global Affairs and Chief Legal Officer, sold 9,093 shares of Class C Capital Stock on March 27, 2026, generating roughly $2.48 million in proceeds. The transactions occurred across multiple trades at prices between $273.91 and $278.30. The stock has risen about 84% over the past year and was trading at $…
Fairmount Funds Management LLC sold 7,000,000 shares of Cogent Biosciences common stock on March 31, 2026, following a conversion of Series A convertible preferred shares into the same number of common shares. The transaction totaled $242,619,999 at $34.66 per share. Cogent's stock has since traded higher, and the company recently secured FDA accep…
Director Bryan H. Lawrence executed multiple sales of Ramaco Resources shares tied to Yorktown Energy Partners funds on March 27 and March 30, 2026, generating proceeds of $3.05 million. The transactions involved both Class A and Class B common stock at prices between $10.3381 and $15.3076 per share. The activity comes as the stock trades at $15.46…
Abeona Therapeutics Chief Executive Officer Seshadri Vishwas sold 29,985 shares on March 31, 2026, generating $131,481 under a Rule 10b5-1 plan. The company has reported its first commercial revenue following FDA approval of ZEVASKYN and recorded $5.8 million in total 2025 revenue. Analysts remain broadly positive but differ on near-term sales pace…
Yorktown IX Associates LLC, a 10 percent owner of Ramaco Resources, Inc. (NASDAQ:METC), disposed of 10,325 shares of Class B common stock in two transactions on March 27 and March 30, 2026, receiving roughly $111,532. After the sales, the firm indirectly continues to hold 1,216,317 Class B shares. The trades come as the stock trades at $15.46, refl…
Yorktown Energy Partners XI, L.P., a ten percent holder of Ramaco Resources, Inc. (NASDAQ: METC), disposed of 10,465 shares of Class B common stock in two transactions on March 27 and March 30, 2026, for roughly $113,044 in proceeds. The sales occurred at weighted average prices of $10.9327 and $10.3381, respectively. Following the disposals, Yorkt…
Yorktown XI Associates LLC, identified as a ten percent owner of Ramaco Resources, Inc. (NASDAQ:METC), disposed of 10,465 shares of Class B Common Stock in two transactions between March 27 and March 30, 2026, generating proceeds of $113,044. The disposition occurred against a backdrop of pronounced share-price volatility and a series of corporate …
Yorktown Energy Partners IX, L.P. — a holder of roughly 10% of Ramaco Resources, Inc. (NASDAQ: METC) — disposed of 10,325 Class B common shares in two trades between March 27 and March 30, 2026, generating $111,532 in proceeds. The disposals took place against a backdrop of recent corporate developments at Ramaco, including Q4 2025 results emphasiz…
Sharplink, Inc. Chief Financial Officer Robert Michael DeLucia executed a sale of 2,848 common shares on March 31, 2026, generating $17,696 at a per-share price of $6.2135. On the same day he also received 10,904 shares at no cash cost as restricted stock units vested. The transactions leave DeLucia with 93,098 directly held shares. The moves come …
Frances Arnold sold 102 shares of Alphabet Inc. Class C Capital Stock on March 30, 2026, for $275.19 per share, yielding proceeds of $28,069. The Class C shares have since risen to $287.56, about 4.5% above the sale price. Arnold continues to hold 18,316 Class C shares directly and multiple tranches of Google Stock Units (GSUs) with staggered vesti…
PubMatic Chief Executive Rajeev K. Goel sold 44,000 Class A shares on March 30, 2026, for about $356,188 under a predetermined Rule 10b5-1 plan. The same day he exercised options to buy 44,000 Class B shares at $1.11 and converted 44,000 Class B shares into Class A. The transaction occurred amid company buybacks and upbeat fourth-quarter 2025 resul…
